President & CEO: Stephen L. Holcombe
HQ: High Point, NC
vTv Therapeutics LLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as the well as treatment of inflammatory disorders and the prevention of muscle weakness. The Company’s drug candidates were discovered with its high-throughput drug discovery platform, Translational Technology®, which translates the functional modulation of human proteins into safe and effective medicines.